Have You Heard? · Peptides Edition · Teleport Strength
Teleport Strength · Research Edition 004

Have You Heard?

THE PEPTIDE

What's Being Talked About · Pros · Cons · Risks · Age Groups

Peptides are everywhere right now — in clinics, on podcasts, in locker rooms. But the hype outruns the science. Before you inject, swallow, or spend $400 a month, here's the unfiltered breakdown on the most talked-about peptides of 2025 — straight from a coach who reads the research and respects your health.

⚠ DISCLAIMER — This content is educational only. No medical advice is given or implied. Always consult a licensed physician before using any peptide or supplement. Many peptides discussed here are NOT FDA-approved for human use.

The Basics First

What Are Peptides, Really?

Peptides are short chains of amino acids — the same building blocks as proteins, just smaller. Your body already makes thousands of them. They act as chemical messengers, telling cells to repair tissue, release hormones, regulate appetite, and more. The ones being sold in clinics and gray markets are synthetic versions designed to mimic or amplify those signals. Some are FDA-approved. Most are not.

The Breakdown

6 Most-Talked-About Peptides in 2025

// 01
BPC-157
Body Protection Compound · 15 Amino Acids
Experimental
Derived from a protein naturally found in human gastric juice. Heavily promoted for healing tendons, ligaments, muscle, gut tissue, and reducing inflammation. Zero FDA approval. Banned by WADA. Largely animal-study evidence with a handful of very small human trials showing promise.
Pros
  • Accelerates tendon + ligament healing in animal models
  • Strong gut healing & anti-inflammatory signals
  • May support nerve regeneration
  • Well-tolerated in limited human studies
  • No significant toxicity found at standard doses
Cons / Risks
  • No large-scale human RCTs — mostly rat studies
  • Promotes angiogenesis — theoretical cancer risk
  • FDA Category 2: cannot be legally compounded
  • Unregulated sources may be contaminated or mislabeled
  • Banned in NCAA + professional sports drug testing
Low-Risk Age Window:
30–50 51–65 (under MD) Under 25: Not Advised
Risk Level:
Moderate
// 02
CJC-1295 + Ipamorelin
GH-Releasing Hormone Stack · Most Popular Combo
Rx/Off-Label
The most discussed peptide stack in fitness circles. CJC-1295 amplifies growth hormone release and extends its duration. Ipamorelin triggers natural GH pulses without spiking cortisol. Together they mimic what your pituitary did in your 20s — boosting GH/IGF-1 for muscle, fat loss, and recovery. Often prescribed off-label at men's health clinics.
Pros
  • Increases lean muscle mass over time
  • Accelerates fat metabolism — especially visceral fat
  • Improves deep sleep and recovery cycles
  • No cortisol/prolactin spike (Ipamorelin)
  • Natural GH rhythm — not synthetic hormone flooding
Cons / Risks
  • CJC-1295 carries immunogenicity risk (immune reaction)
  • Theoretical cancer risk from broad GH elevation
  • Water retention and joint aches common early on
  • Long-term safety data in healthy adults is limited
  • Banned by WADA — competitive athletes are disqualified
Low-Risk Age Window:
40–60 30–39 (supervised) Under 25: Avoid
Risk Level:
Moderate–High
// 03
TB-500
Thymosin Beta-4 Fragment · Healing + Flexibility
Experimental
A synthetic fragment of Thymosin Beta-4 — a protein naturally found in almost every cell. Heavily sought after by athletes for joint health, injury recovery, and flexibility. Often stacked with BPC-157 for synergistic healing effects. Serious red flags in preclinical data.
Pros
  • Promotes tissue repair and vascular growth
  • Increases flexibility and reduces joint stiffness
  • Strong anti-inflammatory properties
  • Systemic healing — works throughout the body
  • Promising for chronic tendon injuries
Cons / Risks
  • Animal studies: accelerated dormant tumor growth
  • Disrupts immune response in preclinical models
  • Zero approved human clinical trials
  • Banned by WADA — no detection window testing
  • Almost entirely unregulated — contamination risk high
Low-Risk Age Window:
40–55 (MD-supervised only) High cancer history: Avoid
Risk Level:
High
// 04
Sermorelin
GHRH Analog · FDA-Approved (Specific Use)
Prescription Rx
One of the few peptides that once held full FDA approval (now withdrawn for growth deficiency). Still widely prescribed off-label at HRT/anti-aging clinics for adults with declining GH levels. Stimulates the pituitary naturally and gently — slower but more conservative than CJC-1295. Favored as the "safer" entry point into GH-axis peptides.
Pros
  • FDA-approved drug history — more safety data than most
  • Steady, natural GH rhythm — no spikes or flooding
  • Improves body composition gradually over months
  • Better sleep quality documented by patients
  • Generally well-tolerated with medical supervision
Cons / Risks
  • Slower results — takes 3–6 months to see changes
  • Requires injection — daily sub-Q protocol
  • Headaches, flushing, injection site irritation
  • May suppress pituitary function if used long-term
  • Not for use with active cancer or tumor history
Low-Risk Age Window:
35–65 25–34 (if GH deficient) No cancer history required
Risk Level:
Low–Moderate
// 05
Semaglutide / GLP-1s
Ozempic · Wegovy · Tirzepatide · Fat Loss
FDA-Approved
The undisputed king of the peptide conversation in 2024–2025. GLP-1 receptor agonists are fully FDA-approved for type 2 diabetes and obesity. They slow digestion, suppress appetite, and regulate insulin. Studies show 15–20% body weight reduction. Now being explored for inflammation, heart disease, Alzheimer's, and addiction. Also the most misused class.
Pros
  • Most rigorously studied peptide class ever — decades of RCTs
  • 15–22% body weight reduction in clinical trials
  • Reduces cardiovascular risk in diabetic patients
  • Anti-inflammatory effects emerging in new research
  • FDA-approved — highest safety accountability
Cons / Risks
  • Nausea, vomiting, diarrhea — often severe early on
  • Significant muscle mass loss alongside fat (up to 40%)
  • Possible pancreatitis and thyroid tumor risk (rare)
  • "Ozempic face" — dramatic facial fat loss
  • Weight rebounds without lifestyle change after stopping
Low-Risk Age Window:
18+ (with BMI indication) Off-label: higher risk
Risk Level:
Low (when prescribed)
// 06
Collagen Peptides
Hydrolyzed Collagen · Joints · Skin · Connective Tissue
OTC / Supplement
The most accessible and safest peptide in this entire list. Hydrolyzed collagen peptides are dietary supplements — no prescription, no injection, no WADA concern. Clinical trials show real benefits for joint pain, skin elasticity, and connective tissue recovery. If you're 18+ and training, this is your lowest-barrier peptide entry point.
Pros
  • RCT-proven: reduces joint pain in aging adults
  • Improves skin elasticity and hydration
  • Supports tendon + ligament repair with resistance training
  • Oral bioavailability — no needles
  • No regulatory concerns — legal everywhere
Cons / Risks
  • Not a performance booster — won't build muscle alone
  • Digestive discomfort in some users
  • Risk if allergic to fish/shellfish (marine collagen)
  • Quality varies wildly between brands
  • Slower results — 8–12 weeks minimum
Low-Risk Age Window:
All ages 18+ Especially 30–70
Risk Level:
Very Low

Side By Side

Quick Reference Comparison

Peptide Primary Goal FDA Status Needle? Best Age Range Risk
BPC-157 Injury healing, gut health Category 2 — No SubQ or oral 30–50 Moderate
CJC-1295 + Ipamorelin GH boost, muscle, fat loss Not approved Yes — SubQ 40–60 Mod–High
TB-500 Healing, flexibility Not approved Yes — SubQ 40–55 MD only High
Sermorelin GH support, anti-aging Off-label Rx Yes — daily 35–65 Low–Mod
Semaglutide / GLP-1 Weight loss, glucose control FDA Approved ✓ Weekly injection 18+ (indicated) Low (Rx)
Collagen Peptides Joint, skin, connective tissue OTC Supplement ✓ No — oral All ages 18+ Very Low

Read This Carefully

The Risks Nobody's Talking About

⚠ The Source Problem

A 2025 JAMA analysis of peptides sold online found that nearly 1 in 4 contained undisclosed compounds not on the label. You may be injecting something entirely different than what's advertised. No amount of perceived benefit justifies unknown injections. Period.

⚠ The Cancer Signal

GH-axis peptides (CJC-1295, TB-500, Ipamorelin) work by promoting broad cellular growth — which is exactly what cancer cells need. Researchers note: "by virtue of inducing broad cell growth, these peptides carry a theoretical cancer risk." For anyone with a family or personal history of cancer, these compounds should be considered high-risk without exception.

⚠ The Stacking Problem

Combining multiple peptides — especially GLP-1s with GH secretagogues or steroids — creates unpredictable synergistic effects. Hypoglycemia risk increases dramatically. Most people stacking peptides are doing so without medical monitoring or bloodwork.

✓ What the Science Actually Supports

The only peptides with robust, multi-year, placebo-controlled human trial data are the GLP-1 class (semaglutide, tirzepatide) and collagen peptides. Everything else currently operates on animal models, small pilot studies, or anecdotal reports from self-experimenters. That doesn't mean the others don't work — it means we don't know enough to call them safe yet.

The Bottom Line

Coach Lionel's Take

// Teleport Strength · Coach Commentary

Look — I get it. You want to recover faster. You want your body to respond the way it did at 25. Peptides aren't magic, but some of them are genuinely interesting science. Here's where I land: Collagen peptides? Easy yes — the research holds up and the risk is near zero. Sermorelin under a real physician who runs labs on you? Reasonable conversation for someone 40+ with documented GH decline. The gray-market BPC-157 you bought off some website and are injecting in your garage? That's where I have to tell you to pump the brakes. The source problem alone is enough to give me pause — 1 in 4 are mislabeled. If you're going to explore peptide therapy, do it with a physician, with bloodwork, with accountability. Your long-term health is the only real PR that matters.

The Research

Sources & Citations

1. Sikiric et al. (2025). Stable Gastric Pentadecapeptide BPC 157 — Pharmaceutics, 17(1), 119.
2. Lee & Walker & Ayadi (2024). Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis — Alt. Therapies in Health & Medicine, 30(10).
3. PMC 12446177 (2025). Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing — Curr Rev Musculoskelet Med.
4. PMC 12313605 (2025). Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
5. Eric Topol, MD (July 2025). The Peptide Craze — Ground Truths (Substack). groundtruths.com
6. UVA Health / Dr. Cate Varney (2025). Should You Trust Trending Peptide Injections? — UVA Today.
7. Healthline (Nov 2025). Peptides for Bodybuilding — reviewed by Courtney L. Gilbert, PT, DPT.
8. Innerbody Research (Jan 2026). Best Peptides for Muscle Growth; BPC-157 Full Guide.
9. Turnock & Hearne (2024). Off-label GLP-1 use for anti-aging — ScienceDirect.
10. WADA (2022). Prohibited List. World Anti-Doping Agency.
11. Raun et al. European Journal of Endocrinology — Ipamorelin selectivity.
12. JAMA (2025). Peptide product ingredient analysis — Journal of the American Medical Association.

Ready to Go Deeper?

Build the Foundation First.
Then Talk About Peptides.

Peptides amplify — but only if there's something there to amplify. Training, nutrition, sleep, and recovery come first. Let Teleport Strength build you a program that earns the results.

ENTER EVENT HORIZON →
© 2025 Teleport Strength LLC · All Rights Reserved · Have You Heard? Edition 004 — Peptides
This content is for educational purposes only. Not medical advice. Always consult a licensed physician.